Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Lumos Diagnostics Holdings Ltd. is conducting a 1 for 1.82 accelerated non-renounceable pro rata entitlement offer to raise approximately A$10.0 million, with shares priced at A$0.038 each. The offer, which is lead managed and underwritten by Bell Potter Securities Limited up to A$6,050,000, is set to close on October 2, 2024. Eligible retail shareholders are advised to read the offer document carefully and consult with professional advisers as needed.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
